How should acute heart failure caused by severe mitral stenosis be treated?

Treatment of Acute Heart Failure Due to Severe Mitral Stenosis

For acute heart failure caused by severe mitral stenosis, initiate immediate medical stabilization with diuretics, beta-blockers or heart rate-regulating calcium channel blockers, and digoxin, followed by urgent percutaneous mitral commissurotomy (PMC) in patients with favorable valve anatomy or mitral valve surgery (typically replacement) in those unsuitable for PMC. 1

Immediate Medical Management

The first priority is hemodynamic stabilization using medical therapy, which can transiently improve symptoms 1:

• Diuretics: Essential for managing pulmonary congestion and volume overload
• Heart rate control: Use beta-blockers, digoxin, or heart rate-regulating calcium channel blockers (e.g., diltiazem, verapamil) to optimize diastolic filling time and reduce pulmonary pressures
• Anticoagulation: Start immediately if atrial fibrillation is present (target INR 2-3) 1

Critical caveat: Medical therapy is purely temporizing—it does not address the underlying mechanical obstruction and definitive intervention must be planned urgently.

Definitive Intervention Strategy

The choice between PMC and surgery depends on valve anatomy and clinical characteristics:

Percutaneous Mitral Commissurotomy (PMC) - First-Line for Suitable Candidates

PMC is indicated as urgent intervention in symptomatic patients with 1:

Favorable characteristics:

• Echocardiographic score ≤8
• Minimal valve calcification (Cormier score <3)
• No left atrial thrombus
• No more than mild mitral regurgitation
• Preserved subvalvular apparatus

PMC should be considered even with suboptimal anatomy if 1:

• No unfavorable clinical characteristics (not NYHA class IV, no severe pulmonary hypertension >50 mmHg, younger age)
• Mild to moderate calcification only
• Surgery carries prohibitive risk

Mitral Valve Surgery - When PMC is Contraindicated

Surgery (typically valve replacement) is indicated when 1:

Absolute contraindications to PMC:

• Left atrial thrombus (unless in appendage only and resolves with 1-3 months anticoagulation)
• More than mild (≥2+) mitral regurgitation
• Severe valve calcification
• Severe destruction of subvalvular apparatus

Unfavorable anatomy for PMC:

• Echocardiographic score >8
• Extensive calcification (Cormier score 3)
• Very small mitral valve area with rigid apparatus
• Severe tricuspid regurgitation requiring concomitant repair

Special Considerations

Degenerative/Calcific Mitral Stenosis in Elderly

This population presents unique challenges 2, 3:

• No commissural fusion exists, making PMC impossible
• Mitral annular calcification makes surgery extremely hazardous
• Consider transcatheter valve implantation (TAVI bioprosthesis in mitral position) in inoperable patients with suitable anatomy 1
• Warning: Surgery for massive mitral annular calcium carries very high mortality 3

Atrial Fibrillation Management

• Maintain on vitamin K antagonists (VKAs), not NOACs 1
• Do not perform cardioversion before intervention—it will not durably restore sinus rhythm in severe mitral stenosis 1
• If atrial fibrillation is recent-onset with only moderate LA enlargement, cardioversion should be performed soon after successful intervention 1

Concomitant Valve Disease

• Severe aortic valve disease + severe MS: Surgery on both valves is preferable 1
• Moderate aortic disease + severe MS: PMC can be performed to postpone combined valve surgery 1

Timing Algorithm

Acute decompensation with severe symptoms:

1. Immediate medical stabilization (diuretics, rate control)
2. Urgent echocardiography (TTE ± TEE) to assess valve anatomy and exclude LA thrombus
3. Within 24-48 hours: PMC if favorable anatomy, or surgery if unsuitable for PMC

The key pitfall: Delaying definitive intervention while attempting prolonged medical management—medical therapy alone cannot adequately relieve the mechanical obstruction causing acute heart failure in severe mitral stenosis.